Encompass Health Co. (NYSE:EHC) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA decreased its position in Encompass Health Co. (NYSE:EHC) by 32.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,461,436 shares of the company’s stock after selling 701,785 shares during the quarter. Massachusetts Financial Services Co. MA owned 1.45% of Encompass Health worth $125,377,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Trillium Asset Management LLC bought a new stake in Encompass Health during the first quarter valued at $4,432,000. TD Asset Management Inc grew its position in shares of Encompass Health by 16.0% during the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock valued at $188,586,000 after buying an additional 314,488 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after acquiring an additional 26,270 shares during the period. Epoch Investment Partners Inc. lifted its holdings in Encompass Health by 102.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 1,399,341 shares of the company’s stock worth $93,364,000 after acquiring an additional 709,593 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its stake in Encompass Health by 85.6% in the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock valued at $1,232,000 after acquiring an additional 6,627 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the completion of the sale, the chief financial officer now directly owns 136,227 shares of the company’s stock, valued at $11,761,839.18. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 2.10% of the company’s stock.

Wall Street Analysts Forecast Growth

EHC has been the topic of several analyst reports. Truist Financial increased their target price on Encompass Health from $100.00 to $104.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. Barclays cut their price objective on shares of Encompass Health from $113.00 to $109.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a report on Wednesday, July 10th. Stephens restated an “overweight” rating and issued a $105.00 target price on shares of Encompass Health in a research report on Tuesday, August 6th. Finally, UBS Group boosted their price target on Encompass Health from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $100.38.

Encompass Health Stock Up 1.2 %

EHC opened at $92.44 on Thursday. The stock’s fifty day moving average is $89.80 and its 200-day moving average is $85.08. Encompass Health Co. has a one year low of $57.55 and a one year high of $94.59. The company has a market capitalization of $9.31 billion, a PE ratio of 24.98, a P/E/G ratio of 1.39 and a beta of 0.88. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35 and a current ratio of 1.35.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.10. Encompass Health had a net margin of 7.88% and a return on equity of 17.83%. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same quarter last year, the firm posted $0.95 EPS. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, equities analysts predict that Encompass Health Co. will post 4.18 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 0.74%. Encompass Health’s dividend payout ratio (DPR) is currently 18.38%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.